Metabolic adaptations of inflammatory macrophages govern ferroptosis susceptibility via the GCH1–BH4–iNOS axis
The Journal of Immunology · 2026
DOI: 10.1093/jimmun/vkag146 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Julia Sauer und 19 weiteren Autor:innen. Beteiligte Einrichtung: Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany. Hauptthemen laut MEDLINE: Macrophages, GTP Cyclohydrolase, Nitric Oxide Synthase Type II, Biopterins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim Pharma GmbH & Co, Max Planck Society, Boehringer Ingelheim Pharma GmbH & Co..
Abstract (Originalsprache)
In inflammatory tissue niches, macrophages encounter intense oxidative stress due to their own production of reactive oxygen and nitrogen species as part of antimicrobial defense. Our findings reveal that inflammatory macrophages deploy distinct, context-dependent redox-protective mechanisms to survive this self-inflicted stress, thereby avoiding ferroptotic cell death. Specifically, LPS-activated macrophages, M(LPS), rely on the GTP cyclohydrolase 1 (GCH1)–tetrahydrobiopterin (BH4) pathway for ferroptosis resistance, whereas LPS + IFN-γ–activated macrophages, M(LPS–IFN-γ), depend primarily on nitric oxide produced by inducible nitric oxide synthase (iNOS)—with the BH4 pathway suppressing cell death in the absence of nitric oxide. These distinct adaptations highlight a novel GCH1–BH4–iNOS axis that governs macrophage ferroptosis susceptibility. In both the LPS or the LPS + IFN-γ–activated settings, the redox-protective phenotype is reversible: Removal of inflammatory stimuli abolishes the protection, indicating that this metabolic programming requires continuous stimulation and is not a permanently fixed state. These findings uncover redox metabolism-guided metabolic distinctions between inflammatory macrophages and reveal how they preserve viability over prolonged inflammatory activation. Ultimately, our findings establish the GCH1–BH4–iNOS axis as a central, targetable mechanism to manipulate macrophage ferroptosis resistance for therapeutic purposes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany.
- Department of Biology, Graduate School of Biological Sciences, University of Konstanz, Konstanz, Germany.
- Department of Immunoregulation, Max Planck Institute of Biochemistry, Martinsried, Germany.
- Mass Spectrometry Core Facility, Max Planck Institute of Biochemistry, Martinsried, Germany.
- Mikrobiologisches Institut-Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
- C.H. Boehringer Sohn AG & Co. KG, Biberach an der Riß, Germany.
ORCID-Profile: Julia Sauer, Peter J Murray
Förderung
- Boehringer Ingelheim Pharma GmbH & Co
- Max Planck Society
- Boehringer Ingelheim Pharma GmbH & Co.
- European Union
- German Research Foundation
- ImmunoMicroTope
Zitieren
APA
Sauer, J., Ogger, P. P., Dukic, J., Nessensohn, A., Gabler, S., Schwenzer, A. K., Unsöld, J. K., Cortès, B. M., Steigenberger, B., Fernandez Perez, N., Strasser, A., Dias Requiao, R., Schleicher, U., Griesser, E., Bretschneider, T., Gantner, F., Thomas, M. J., Watson, C. K., El Kasmi, K. C., & Murray, P. J. (2026). Metabolic adaptations of inflammatory macrophages govern ferroptosis susceptibility via the GCH1–BH4–iNOS axis. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkag146
Vancouver
Sauer J, Ogger PP, Dukic J, Nessensohn A, Gabler S, Schwenzer AK, et al. Metabolic adaptations of inflammatory macrophages govern ferroptosis susceptibility via the GCH1–BH4–iNOS axis. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkag146
BibTeX
@article{Sauer2026,
author = {Sauer, Julia and Ogger, Patricia P and Dukic, Jasmina and Nessensohn, Alina and Gabler, Svenja and Schwenzer, Ann-Katrin and Unsöld, Julia Kirstin and Cortès, Birgit Maria and Steigenberger, Barbara and Fernandez Perez, Nuria and Strasser, Alexander and Dias Requiao, Rodrigo and Schleicher, Ulrike and Griesser, Eva and Bretschneider, Tom and Gantner, Florian and Thomas, Matthew James and Watson, Carolin Kirstin and El Kasmi, Karim Christian and Murray, Peter J},
title = {Metabolic adaptations of inflammatory macrophages govern ferroptosis susceptibility via the GCH1–BH4–iNOS axis},
journal = {The Journal of Immunology},
year = {2026},
doi = {10.1093/jimmun/vkag146}
}
EUVIMED